BlossomHill Therapeutics, Inc.

BlossomHill Therapeutics, Inc. financial statements

BlossomHill Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 60.55MEODHD
Cash and equivalentsUSD 136.68MEODHD
Total debtUSD 22.4MEODHD

BlossomHill Therapeutics, Inc. financials on 6ix · BlossomHill Therapeutics, Inc. on 6ix